ASX Announcement DR MICHAEL BAKER COMMENCES AS CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR Melbourne, Australia – 5 October 2026: Percheron Therapeutics Limited (ASX: PER) (‘the Company’), an international biotechnology company focused on developing novel therapies for oncology and rare...